These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
499 related articles for article (PubMed ID: 15234054)
1. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse. Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054 [TBL] [Abstract][Full Text] [Related]
2. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases. Raju U; Ariga H; Koto M; Lu X; Pickett J; Valdecanas D; Mason KA; Milas L Radiother Oncol; 2006 Aug; 80(2):185-91. PubMed ID: 16905211 [TBL] [Abstract][Full Text] [Related]
3. [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma]. Song Y; Shen K; Tang PP Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):761-4. PubMed ID: 18307904 [TBL] [Abstract][Full Text] [Related]
4. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy. Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567 [TBL] [Abstract][Full Text] [Related]
5. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo. Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin. Kirichenko AV; Rich TA; Newman RA; Travis EL Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987 [TBL] [Abstract][Full Text] [Related]
7. The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells. Jung C; Motwani M; Kortmansky J; Sirotnak FM; She Y; Gonen M; Haimovitz-Friedman A; Schwartz GK Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6052-61. PubMed ID: 14676132 [TBL] [Abstract][Full Text] [Related]
9. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec). Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359 [TBL] [Abstract][Full Text] [Related]
10. A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer. Shapiro GI; Supko JG; Patterson A; Lynch C; Lucca J; Zacarola PF; Muzikansky A; Wright JJ; Lynch TJ; Rollins BJ Clin Cancer Res; 2001 Jun; 7(6):1590-9. PubMed ID: 11410495 [TBL] [Abstract][Full Text] [Related]
11. [Synergism of antitumor effects on ovarian carcinoma using autocatalytic caspase-3 combined with flavopiridol]. Song Y; Shen K; Xu F Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):781-6. PubMed ID: 21176562 [TBL] [Abstract][Full Text] [Related]